Fort Sheridan Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $379K | Sell |
|
|||||
|
2025
Q2 | $446K | Sell |
|
|||||
|
2025
Q1 | $677K | Buy |
|
|||||
|
2024
Q4 | $389K | Buy |
|
|||||
|
2024
Q3 | $355K | Buy |
|
|||||
|
2024
Q2 | $249K | Buy |
|
|||||
|
2024
Q1 | $237K | Sell |
|
|||||
|
2023
Q4 | $254K | Buy |
|
|||||
|
2023
Q3 | $283K | Sell |
|
|||||
|
2023
Q2 | $376K | Sell |
|
|||||
|
2023
Q1 | $421K | Buy |
|
|||||
|
2022
Q4 | $423K | Sell |
|
|||||
|
2022
Q3 | $426K | Sell |
|
|||||
|
2022
Q2 | $474K | Buy |
|
|||||
|
2022
Q1 | $374K | Buy |
|
|||||
|
2021
Q4 | $319K | Buy |
|
|||||
|
2021
Q3 | $284K | Sell |
|
|||||
|
2021
Q2 | $323K | Sell |
|
|||||
|
2021
Q1 | $321K | Buy |
|